Searched for
ORAL CONTRACEPTIVE MEDICINE
What are GLP-1 medicines? Do they help with weight loss and diabetes, and what are their side effects?GLP-1 medications are prescription treatments used in the UK to manage type 2 diabetes and, in certain cases, medically supervised weight l...- India’s cheap birth control pills in US could vanish under Trump’s 250% tariff threatDonald Trump's tariff threat jeopardizes affordable Indian medicines in the US. Birth control pills, hypertension, and depression treatment...
- UK Summer Bank Holiday in August: NHS offers emergency health advice to cover everything from dental care to mental health for a smooth holidayNational Health Service Greater Manchester advises citizens to prepare for the upcoming summer bank holiday. They suggest planning for heal...
- The estrogen nobody told you about is changing hormone care — here’s why it matters nowEstrogen hormone therapy: A new estrogen called Estetrol or E4 is gaining attention. It is produced during pregnancy. Unlike other estrogen...
- HLL Lifecare reports annual condom production of 221.7 crHLL Lifecare, a Kerala-based PSU, produces 221.7 crore condoms annually, solidifying its position as a leading global manufacturer. With ei...
- Drugs panel considering proposal to rein in sale of OTC medicines to prevent misuseIndia's drug advisory board is considering restricting over-the-counter medication sales to prevent misuse and ensure patient safety. The p...
- Deadly professions! Hairdressers, beauticians & accountants at higher risk of developing ovarian cancer, says studyA new study published in the BMJ Journal Occupational & Environmental Medicine has found that workers such as hairdressers, beauticians and...
- Hormonal contraceptives increase the risk of breast cancer, suggests new studyBeware of becoming overdependent on contraceptives!
- Use of hormonal birth control pills may increase breast cancer risk by 20-30%, says studyThe use of progestogen-only contraceptives has increased substantially in recent years.
- Lupin recalls 4,113 cartons of oral contraceptive medicine in US marketThe company is recalling the lot due to it being "Subpotent Drug", the US health regulator noted in the report.
- Scientists believe coronavirus may increase risk of blood clots in pregnant womenThe virus aggravates the risk of blood clots and strokes associated with oral contraceptive pills.
- Sun, Dr Reddy's among 7 Indian pharma majors sued in US for price riggingThe lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.
- Cheap contraceptive pills from Bangladesh flood Assam, government worriedBangladesh, which has a robust family-planning programme, distributes sukhi pills for free which have also made their way across the border...
- How Warren Buffett’s family secretly funded a birth control revolutionIn the past decade, the Susan Thompson Buffett Foundation has become the most influential supporter of research on IUDs and expanding acces...
- Good news trickles in for Ranbaxy, FDA approves Gurgaon & Romania R&D centresSun will acquire Ranbaxy in an all-share deal that will give it a 56% stake in the combined entity while Daiichi Sankyo will have 9% holdin...
- Glenmark Pharma rallies over 3% on talks to sell oral contraceptive unit"Given complex manufacturing processes and high investments, the competition is low in the segment and typically attracts only a few player...
- Glenmark in talks to sell oral contraceptive unitThe company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.
- Govt's efforts to fix essential drugs' prices hit roadblockThe regulator (NPPA) is also struggling to calculate price caps for another 150 such medicines because it believes the database is inadequa...
- Hot stock: Experts bullish on Lupin in weak marketWhile most stocks have corrected and are below 200- Daily Moving Averages, Lupin is showing strength as weakness in rupee augurs well for i...
- Baring may acquire 15% in Famy CareBaring Private Equity Partners (India) is the front-runner to buy about 15% stake in Mumbai-based drugmaker Famy Care for around $40 millio...
Load More
